LAW576A

040441

This course navigates the drug development path stretching across the pre-clinical and post-marketing divide from the full range of drug regulation, including drug discovery, innovative drug development tools, and the post-approval phase. Intellectual Property protection and evaluation will be covered, along with FDA-enforced market exclusivity and FDA-expedited review programs. The course concludes with international regulatory perspectives, including the European Medicines Agency, the costs involved to bring drugs through the clinical trials to market in the US and abroad, and how this affects future investment and strategy.

GRD - Regular Plus/Minus Grades A, B, C, D, E

Law

LAW476A